期刊文献+

Application of Support Vector Machine to Predict 5-year Survival Status of Patients with Nasopharyngeal Carcinoma after Treatment

应用支持向量机方法对鼻咽癌治疗后5年生存状态的预测
下载PDF
导出
摘要 Objective: Support Vector Machine (SVM) is a machine-learning method, based on the principle of structural risk minimization, which performs well when applied to data outside the training set. In this paper, SVM was applied to predict 5-year survival status of patients with nasopharyngeal carcinoma (NPC) after treatment, we expect to find a new way for prognosis studies in cancer so as to assist right clinical decision for individual patient. Methods: Two modelling methods were used in the study; SVM network and a standard parametric logistic regression were used to model 5-year survival status. And the two methods were compared on a prospective set of patients not used in model construction via receiver operating characteristic (ROC) curve analysis. Results: The SVM1, trained with the 25 original input variables without screening, yielded a ROC area of 0.868, at sensitivity to mortality of 79.2% and the specificity of 94.5%. Similarly, the SVM2, trained with 9 input variables which were obtained by optimal input variable selection from the 25 original variables by logistic regression screening, yielded a ROC area of 0.874, at a sensitivity to mortality of 79.2% and the specificity of 95.6%, while the logistic regression yielded a ROC area of 0.751 at a sensitivity to mortality of 66.7% and gave a specificity of 83.5%. Conclusion: SVM found a strong pattern in the database predictive of 5-year survival status. The logistic regression produces somewhat similar, but better, results. These results show that the SVM models have the potential to predict individual patient's 5-year survival status after treatment, and to assist the clinicians for making a good clinical decision.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2006年第1期8-12,共5页 中德临床肿瘤学杂志(英文版)
关键词 support vector machine logistic regression nasopharyngeal carcinoma predictive model RADIOTHERAPY ROC curve 鼻咽癌 治疗 生存质量 病理机制
  • 相关文献

参考文献2

二级参考文献17

  • 1卢泰祥,李家尧,胡永红,张恩罴.鼻咽癌颅底骨破坏的临床研究[J].中华耳鼻咽喉科杂志,1994,29(5):295-298. 被引量:24
  • 2卢泰祥,胡永红,张恩罴,李家尧.鼻咽癌颅底蔓延的放射治疗疗效分析[J].中国肿瘤临床,1997,24(2):115-117. 被引量:7
  • 3Henle G, Henle W. Epstein-Barrvirus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.Int J Cancer, 1976, 17: 1-7.
  • 4Zeng Y, Zhang LG, Li HY, et al. Serological mass survey for early detection ofnasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer, 1982, 29: 139-141.
  • 5Zheng SA, Liang JS, Guo YQ, et al. Dynamic observation on the incidence andmortality rate of the nasopharyngeal carcinoma (NPC) in Zhongshan City 1970-1984. Chin JEpidemiol, 1991, 12: 106-110.
  • 6Zong YS, Li JY, Peng XY, et al. Nasopharyngeal carcinoma (NPC) mortality rates intwo districts of Guangdong Province and their relation to IgA antibody level against EBvirus capsid antigen. Chin J Oncol, 1992, 14: 103-105.
  • 7Zong YS, Sham JS, Ng MH, et al. Immunoglobulin A against viral capsid antigen ofEpstein-Barr virus and indirect mirror examination of the nasopharynx in the detection ofasymptomatic nasopharyngeal carcinoma. Cancer, 1992, 69: 3-7.
  • 8Liu YX, Zeng Y, Dong WP, et al. Detection of EB virus-specific IgA antibody frompatients with nasopharyngeal carcinoma by immunoenzymic method. Chin J Oncol, 1979, 1:8-12.
  • 9Shanmugaratnam K, Sobin LH. The World Health Organization histologicalclassification of tumors of the upper respiratory tract and ear. A commentary on thesecond edition. Cancer, 1993, 71: 2689-2697.
  • 10Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997).Union International Contre le Cancer and the American Joint Committee on Cancer. Cancer,1997, 80: 1803-1804.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部